In 2013, NVLX -Nuvilex acquired exclusive worldwid
Post# of 144482
Posted On: 02/07/2014 9:36:18 AM
In 2013, NVLX -Nuvilex acquired exclusive worldwide and patented rights to use this cellulose-based encapsulation technology for the development of treatments for all forms of cancer. Medical Marijuana Sciences intends to take advantage of the opportunity to employ the Cell-in-a-Box™ encapsulation technology together with constituents of Cannabis for the development of treatments for some of the deadliest and most difficult-to-treat forms of cancer, such as gliomas (a type of brain cancer) and pancreatic cancer. The type of cells encapsulated using the Cell-in-a-Box™ live-cell encapsulation technology will be those that optimize the effectiveness and safety of naturally-occurring cannabinoids against such cancers in the same way that the technology was used in developing a unique treatment for pancreatic cancer.
(0)
(0)Scroll down for more posts ▼